|Adherence to medication and life style recommendations (Primary outcomes)||Using the distribution on the Morisky scale  of low, medium, and high adherence ratios, a post CHEP effect shift of 10% to a higher category will be defined as a significant improvement in adherence.|
|Blood pressure (Secondary outcome)||Blood pressure decrease of >10% systolic or diastolic or blood pressure at target level (patients without diabetes or established CVD: <140 mmHg systolic and <90 mmHg diastolic, patients with diabetes, renal disease or established CVD: <130 mm Hg systolic and <80 mmHg diastolic).|
|Body mass index (kg/m2 )||
No CVD risk: <25|
Moderate CVD risk: 25-30
High CVD risk: >30
In patients with a BMI >25 any reduction of BMI at 6 months will be regarded as an improvement.